INM

InMed Pharmaceuticals Inc. - Common Shares (INM)

About InMed Pharmaceuticals Inc. - Common Shares (INM)

InMed Pharmaceuticals, Inc. is a pharmaceutical drug development company, which engages in developing small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

Details

Daily high

$1.46

Daily low

$1.37

Price at open

$1.38

52 Week High

$2.50

52 Week Low

$0.58

Market cap

7.5M

Dividend yield

Volume

2,123

Avg. volume

75,854

P/E ratio

-.44

InMed Pharmaceuticals Inc. - Common Shares News